Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: A systematic review

References

• Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR. (2007). Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect, 115, 1670–6.
   PubMed Web of Science ®Google Scholar
• Arbuckle TE, Kubwabo C, Walker M, Davis K, Lalonde K, Kosarac I, et al. (2013). Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. Int J Hyg Environ Health, 216, 184–94.
   PubMed Web of Science ®Google Scholar
• Aylward LL, Hays SM, Kirman CR, Marchitti SA, Kenneke JF, English C, et al. (2014). Relationships of chemical concentrations in maternal and cord blood: a review of available data. J Toxicol Environ Health B Crit Rev, 17, 175–203.
   PubMed Web of Science ®Google Scholar
• Benninghoff AD, Bisson WH, Koch DC, Ehresman DJ, Kolluri SK, Williams DE. (2011). Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicol Sci, 120, 42–58.
   Google Scholar
• Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hochberg Z. (2003). Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol, 102, 232–41.
   Google Scholar
• Bonzini M, Coggon D, Palmer KT. (2007). Risk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic review. Occup Environ Med, 64, 228–43.
   PubMed Web of Science ®Google Scholar
• Brantsæter AL, Birgisdottir BE, Meltzer HM, Kvalem HE, Alexander J, Magnus P, Haugen M. (2012). Maternal seafood consumption and infant birth weight, length and head circumference in the Norwegian Mother and Child Cohort Study. Br J Nutr, 107, 436–44.
   PubMed Web of Science ®Google Scholar
• Brantsæter AL, Whitworth KW, Ydersbond TA, Haug LS, Haugen M, Knutsen HK, et al. (2013). Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ Int, 54, 74–84.
   PubMed Web of Science ®Google Scholar
• Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, et al. (2011). Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag, 7, 513–41.
   PubMedGoogle Scholar
• Butenhoff JL, Kennedy GL Jr, Frame SR, O’Connor JC, York RG. (2004). The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology, 196, 95–116.
   PubMed Web of Science ®Google Scholar
• Butenhoff JL, Olsen GW, Pfahles-Hutchens A. (2006). The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect, 114, 1776–82.
   PubMed Web of Science ®Google Scholar
• Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. (2007). Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect, 115, 1596–602.
   PubMed Web of Science ®Google Scholar
• Chen MH, Ha EH, Wen TW, Su YN, Lien GW, Chen CY, et al. (2012). Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One, 7, e42474.
   PubMed Web of Science ®Google Scholar
• Darrow LA, Stein CR, Steenland K. (2013). Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005–2010. Environ Health Perspect, 121, 1207–13.
   PubMed Web of Science ®Google Scholar
• DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR. (2012). Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol, 40, 300–11.
   PubMed Web of Science ®Google Scholar
• Du G, Hu J, Huang H, Qin Y, Han X, Wu D, et al. (2013). Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo. Environ Toxicol Chem, 32, 353–60.
   PubMed Web of Science ®Google Scholar
• Ehresman DJ, Froehlich JW, Olsen GW, Chang S-C, Butenhoff JL. (2007). Comparison of Human Whole Blood, Plasma, and Serum Matrices for the Determination of Perfluorooctanesulfonate (PFOS), Perfluorooctanoate (PFOA), and Other Fluorochemicals. Environ Res, 103, 176–84.
   PubMed Web of Science ®Google Scholar
• Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM. (2006). Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med, 48, 771–9.
   PubMed Web of Science ®Google Scholar
• Environment Canada. (2010). Environmental performance agreement (“agreement”) respecting perfluorinated carboxylic acids (PFCAs) and their precursors in perfluorochemical products sold in Canada. Available at: http://ec.gc.ca.ez.statsbiblioteket.dk:2048/epe-epa/default.asp?lang = En&n = 81AE80CE-1. Accessed on 23 July 2014.
   Google Scholar
• European Parliament. (2006). Directive 2006/122/EC of the European Parliament and of the Council of 12 December 2006. Official Journal of the EU, 27 December 2006, L372/32-L372/34. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri = CELEX:32006L0122&from = EN. Accessed on 23 July 2014.
   Google Scholar
• Fei C, McLaughlin JK, Tarone RE, Olsen J. (2007). Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect, 115, 1677–82.
   PubMed Web of Science ®Google Scholar
• Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, et al. (2010). Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol, 44, 7123–9.
   PubMed Web of Science ®Google Scholar
• Glynn A, Berger U, Bignert A, Ullah S, Aune M, Lignell S, Darnerud PO. (2012). Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996–2010. Environ Sci Technol, 46, 9071–9.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C. (2012). Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307, 391–7.
   PubMed Web of Science ®Google Scholar
• Grasty RC, Wolf DC, Grey BE, Lau CS, Rogers JM. (2003). Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B Dev Reprod Toxicol, 68, 465–71.
   PubMed Web of Science ®Google Scholar
• Grice MM, Alexander BH, Hoffbeck R, Kampa DM. (2007). Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med, 49, 722–9.
   PubMed Web of Science ®Google Scholar
• Hamm MP, Cherry NM, Chan E, Martin JW, Burstyn I. (2010). Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol, 20, 589–97.
   PubMed Web of Science ®Google Scholar
• Han X, Nabb DL, Russel MH, Kennedy GL, Rickard RW. (2012). Renal elimination of perfluorocarboxylates (PFCAs). Chem Res Toxicol, 25, 35–46.
   PubMed Web of Science ®Google Scholar
• Haug LS, Thomsen C, Brantsæter AL, Kvalem HE, Haugen M, Becher G, et al. (2010). Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environ Int, 36, 772–8.
   PubMed Web of Science ®Google Scholar
• Haughom B, Spydevold O. (1992). The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim Biophys Acta, 1128, 65–72.
   PubMed Web of Science ®Google Scholar
• Henry ND, Fair PA. (2011). Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J Appl Toxicol, 33, 265–72.
   PubMed Web of Science ®Google Scholar
• Inoue K, Okada F, Ito R, Kato S, Saski S, Nakajima S, et al. (2004). Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a suspectible population during pregnancy. Environ Health Perspect, 112, 1204–7.
   PubMed Web of Science ®Google Scholar
• Jain RB. (2013). Effect of pregnancy on the levels of selected perfluoroalkyl compounds for females aged 17–39 years: data from National Health and Nutrition Examination Survey 2003–2008. J Toxicol Environ Health A, 76, 409–21.
   PubMed Web of Science ®Google Scholar
• Johnson PI, Sutton P, Atchley DS, Koustas E, Lam J, Sen S, et al. (2014). The navigation guide – Evidence-based medicine meets environmental health: Systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect. [Online 25 June 2014].
   Web of Science ®Google Scholar
• Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A. (2000). Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology, 11, 315–9.
   PubMed Web of Science ®Google Scholar
• Kantiani L, Llorca M, Sanchís J, Farré M, Barceló D. (2010). Emerging food contaminants: a review. Anal Bioanal Chem, 398, 2413–27.
   PubMed Web of Science ®Google Scholar
• Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. (2011). Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999–2008. Environ Sci Technol, 45, 8037–45.
   PubMed Web of Science ®Google Scholar
• Kennedy GL Jr, Butenhoff JL, Olsen GW, O’Connor JC, Seacat AM, Perkins RG, et al. (2004). The toxicology of perfluorooctanoate. Crit Rev Toxicol, 34, 351–84.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, et al. (2011). Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol, 45, 7465–72.
   PubMed Web of Science ®Google Scholar
• Kjeldsen LS, Bonefeld-Jørgensen EC. (2013). Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int, 20, 8031–44.
   PubMed Web of Science ®Google Scholar
• Kraugerud M, Zimmer KE, Ropstad E, Verhaegen S. (2011). Perfluorinated compounds differentially affect steroidogenesis and viability in the human adrenocortical carcinoma (H295R) in vitro cell assay. Toxicol Lett, 205, 62–8.
   PubMed Web of Science ®Google Scholar
• Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci, 74, 382–92.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kim MK, Bae J, Yang JH. (2013). Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea. Chemosphere, 90, 1603–9.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, b2700.
   PubMed Web of Science ®Google Scholar
• Loccisano AE, Longnecker MP, Campbell JL Jr, Andersen ME, Clewell HJ III. (2013). Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages. J Toxicol Environ Health A, 76, 25–57.
   PubMed Web of Science ®Google Scholar
• Long M, Ghisari M, Bonefeld‐Jørgensen EC. (2013). Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Res Int, 20, 8045–56.
   Google Scholar
• Loveless SE, Finlay C, Everds NE, Frame SR, Gillies PJ, O’Connor JC, et al. (2006). Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology, 220, 203–17.
   PubMed Web of Science ®Google Scholar
• Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL. (2005). Neonatal mortality from in utero exposure to perfluorooctane sulfonate (PFOS) in Sprague–Dawley rats: dose–response, and biochemical and pharmacokinetic parameters. Toxicology, 215, 149–69.
   PubMed Web of Science ®Google Scholar
• Luo ZC, Kierans WJ, Wilkins R, Liston RM, Mohamed J, Kramer MS. (2004). Disparities in birth outcomes by neighborhood income: temporal trends in rural and urban areas, British Columbia. Epidemiology, 15, 679–86.
   PubMed Web of Science ®Google Scholar
• Maisonet M, Terrell ML, McGeehin MA, Christensen KY, Holmes A, Calafat AM, Marcus M. (2012). Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in british girls. Environ Health Perspect, 120, 1432–7.
   PubMed Web of Science ®Google Scholar
• Martin MT, Brennan RJ, Hu W, Ayanoglu E, Lau C, Ren H, et al. (2007). Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol Sci, 97, 595–613.
   PubMed Web of Science ®Google Scholar
• Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. (2007). Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health, 80, 643–8.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med, 6, e1000097.
   PubMed Web of Science ®Google Scholar
• Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, Foster WG. (2008). Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res, 108, 56–62.
   PubMed Web of Science ®Google Scholar
• Morken NH, Travlos GS, Wilson RE, Eggesbø M, Longnecker MP. (2014). Maternal glomerular filtration rate in pregnancy and fetal size. PLoS One, 9, e101897.
   Google Scholar
• Moser K, Li L, Power C. (2003). Social inequalities in low birth weight in England and Wales: trends and implications for future population health. J Epidemiol Community Health, 57, 687–91.
   PubMed Web of Science ®Google Scholar
• Nolan LA, Nolan JM, Shofer FS, Rodway NV, Emmet EA. (2009). The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol, 27, 231–8.
   Google Scholar
• Olsen GW, Burris JM, Burlew MM, Mandel JH. (2003). Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med, 45, 260–70.
   Google Scholar
• Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR. (2007). Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect, 115, 1298–305.
   Google Scholar
• Olsen GW, Butenhoff JL, Zobel LR. (2009). Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol, 27, 212–30.
   PubMed Web of Science ®Google Scholar
• Olsen GW, Zobel LR. (2007). Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health, 81, 231–46.
   PubMed Web of Science ®Google Scholar
• Papachatzi E, Dimitriou G, Dimitropoulos K, Vantarakis A. (2013). Pre-pregnancy obesity: maternal, neonatal and childhood outcomes. J Neonatal Perinatal Med, 6, 203–16.
   PubMedGoogle Scholar
• Rylander C, Sandanger TM, Frøyland L, Lund E. (2010). Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study. Environ Sci Technol, 44, 5225–32.
   PubMed Web of Science ®Google Scholar
• Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E. (1993). Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol, 81, 1029–33.
   PubMed Web of Science ®Google Scholar
• Sarigiannis DA, Hansen U. (2012). Considering the cumulative risk of mixtures of chemicals - a challenge for policy makers. Environ Health, 11, S18.
   Web of Science ®Google Scholar
• Savitz DA. (2007). Biomarkers of perfluorinated chemicals and birth weight. Environ Health Perspect, 115, 528–9.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Stein CR, Bartell SM, Elston B, Gong J, Shin HM, Wellenius GA. (2012a). Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology, 23, 386–92.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Stein CR, Elston B, Wellenius GA, Bartell SM, Shin HM, et al. (2012b). Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley. Environ Health Perspect, 120, 1201–7.
   PubMed Web of Science ®Google Scholar
• Shoeib M, Harner TM, Webster G, Lee SC. (2011). Indoor sources of poly- and perfluorinated compounds (PFCS) in Vancouver, Canada: implications for human exposure. Environ Sci Technol, 45, 7999–8005.
   PubMed Web of Science ®Google Scholar
• Stein CR, Savitz DA, Dougan M. (2009). Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol, 170, 837–46.
   PubMed Web of Science ®Google Scholar
• Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, et al. (2003). Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci, 74, 369–81.
   PubMed Web of Science ®Google Scholar
• Tilton SC, Orner GA, Benninghoff AD, Carpenter HM, Hendricks JD, Pereira CB, Williams DE. (2008). Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout. Environ Health Perspect, 116, 1047–55.
   PubMed Web of Science ®Google Scholar
• [UNEP] UN Environment Programme. (2009). Governments unite to step-up reduction on global DDT reliance and add nine new chemicals under international treaty. Available at: http://chm.pops.int/Convention/Pressrelease/COP4Geneva8May2009/tabid/542/language/en-US/Default.aspx. Accessed on 23 July 2014.
   Google Scholar
• [USEPA] US Environmental Protection Agency. (2000). EPA and 3M announce phase-out of PFOS. Available at: http://yosemite.epa.gov/opa/admpress.nsf/0/33aa946e6cb11f35852568e1005246b4. Accessed on 23 July 2014.
   Google Scholar
• [USEPA] US Environmental Protection Agency. (2006). 2010/2015 PFOA Stewardship Program. Available at: http://www.epa.gov/opptintr/pfoa/pubs/stewardship/. Accessed on 23 July 2014.
   Google Scholar
• Viswanathan M, Siega-Riz AM, Moos MK, Deierlein A, Mumford S, Knaack J, et al. (2008). Outcomes of maternal weight gain. Evid Rep Technol Assess (Full Rep), 168, 1–223.
   PubMedGoogle Scholar
• Wahabi HA, Mandil AA, Alzeidan RA, Bahnassy AA, Fayed AA. (2013). The independent effects of second hand smoke exposure and maternal body mass index on the anthropometric measurements of the newborn. BMC Public Health, 13, 1058.
   PubMed Web of Science ®Google Scholar
• Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, et al. (2013). Association between Perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study. Environ Health, 12, 76.
   PubMed Web of Science ®Google Scholar
• Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, et al. (2009). Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect, 117, 660–7.
   PubMed Web of Science ®Google Scholar
• Wei Y, Dai J, Liu M, Wang J, Xu M, Zha J, Wang Z. (2007). Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ Toxicol Chem, 26, 2440–7.
   PubMed Web of Science ®Google Scholar
• Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, et al. (2012). Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study. Am J Epidemiol, 175, 1209–16.
   PubMed Web of Science ®Google Scholar
• Wilcox AJ. (2010). Fertility and Pregnancy: An Epidemiologic Perspective. New York, USA: Oxford University Press.
   Google Scholar
• Wilcox MA, Chang AM, Johnson IR. (1996). The effects of parity on birthweight using successive pregnancies. Acta Obstet Gynecol Scand, 75, 459–3.
   PubMed Web of Science ®Google Scholar
• Wilcox AJ, Weinberg CR, Basso O. (2011). On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol, 174, 1062–8.
   PubMed Web of Science ®Google Scholar
• Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, et al. (2007). Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci, 95, 462–73.
   PubMed Web of Science ®Google Scholar
• Wu K, Xu X, Peng L, Liu J, Guo Y, Huo X. (2012). Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes. Environ Int, 48, 1–8.
   PubMed Web of Science ®Google Scholar
• Xiong X, Buekens P, Alexander S, Demianczuk N, Wollast E. (2000). Anemia during pregnancy and birth outcome: a meta-analysis. Am J Perinatol, 17, 137–46.
   PubMed Web of Science ®Google Scholar
• Yu WG, Liu W, Jin YH. (2009a). Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem, 28, 990–6.
   PubMed Web of Science ®Google Scholar
• Yu WG, Liu W, Jin YH, Liu XH, Wang FQ, Liu L, Nakayama SF. (2009b). Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol, 43, 8416–22.
   PubMed Web of Science ®Google Scholar